Teva Pharmaceutical Industries Aktie
20,50 EUR +1,80 EUR +9,63 %
STU
21,32 USD +0,12 USD +0,57 %
BTT
Werbung
Teva Pharmaceutical Industries Rating
Teva Pharmaceutical Industries Ltd. (spons. ADRs) Aktie Moody's Rating
WR
C
A3
Aaa
Investmentwürdig - Hohe Sicherheit
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
| Rating | Rating entzogen | Rating Typ Bank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
| Letzte Aktion | Withdrawn | Moody's Büro in | USA |
Anleihen von Teva Pharmaceutical Industries Ltd. (spons. ADRs) mit Moody's Ratings
| Emittent | Anzahl Anleihen | Ratings |
|---|---|---|
| Teva Pharmaceutical Finance Co. LLC | 2 | Ba2 |
Moody's Ratings Peer Group
| Aktie | Rating |
|---|---|
| AstraZeneca PLC | A2 |
| Merck Co. | A1 |
| Pfizer Inc. | A1 |
| Pfizer Inc. | A2 |
| Sanofi S.A. | A1 |